- Home
- SRPT vs ASTH Comparison
SRPT vs ASTH Comparison
Compare SRPT & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRPT
- ASTH
- Stock Information
- Founded
- SRPT 1980
- ASTH 1994
- Country
- SRPT United States
- ASTH United States
- Employees
- SRPT N/A
- ASTH N/A
- Industry
- SRPT Biotechnology: Pharmaceutical Preparations
- ASTH Professional Services
- Sector
- SRPT Health Care
- ASTH Consumer Discretionary
- Exchange
- SRPT Nasdaq
- ASTH Nasdaq
- Market Cap
- SRPT 1.7B
- ASTH 1.7B
- IPO Year
- SRPT 1997
- ASTH N/A
- Fundamental
- Price
- SRPT $18.19
- ASTH $25.28
- Analyst Decision
- SRPT Buy
- ASTH Strong Buy
- Analyst Count
- SRPT 25
- ASTH 8
- Target Price
- SRPT $64.00
- ASTH $53.29
- AVG Volume (30 Days)
- SRPT 7.9M
- ASTH 266.4K
- Earning Date
- SRPT 08-06-2025
- ASTH 08-06-2025
- Dividend Yield
- SRPT N/A
- ASTH N/A
- EPS Growth
- SRPT N/A
- ASTH N/A
- EPS
- SRPT N/A
- ASTH 0.73
- Revenue
- SRPT $2,233,371,000.00
- ASTH $2,250,574,000.00
- Revenue This Year
- SRPT $26.87
- ASTH $34.97
- Revenue Next Year
- SRPT $3.15
- ASTH $21.52
- P/E Ratio
- SRPT N/A
- ASTH $34.63
- Revenue Growth
- SRPT 59.15
- ASTH 54.81
- 52 Week Low
- SRPT $16.88
- ASTH $23.12
- 52 Week High
- SRPT $155.95
- ASTH $63.20
- Technical
- Relative Strength Index (RSI)
- SRPT 23.09
- ASTH 47.92
- Support Level
- SRPT $16.88
- ASTH $24.39
- Resistance Level
- SRPT $18.62
- ASTH $25.96
- Average True Range (ATR)
- SRPT 1.40
- ASTH 1.22
- MACD
- SRPT 0.09
- ASTH 0.14
- Stochastic Oscillator
- SRPT 6.41
- ASTH 50.00
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
About ASTH Astrana Health Inc. Common Stock
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.